Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice

Molecular Psychiatry

Volumn 16, Issue 11, 2011, Pages 1068-1070

  Beurel, E ^a   Song, L ^a   Jope, R S ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; GLYCOGEN SYNTHASE KINASE 3; KETAMINE; LITHIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; DEPRESSION; LEARNED HELPLESSNESS; LETTER; LOW DRUG DOSE; MOOD DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 85028117370     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2011.47     Document Type: Letter

References (10)

1. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS et al. Biol Psychiatry 2000; 47: 351-354.
2. Zarate Jr CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA et al. Arch Gen Psychiatry 2006; 63: 856-864.
3. Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M et al. Science 2010; 329: 959-964.
4. Maeng S, Zarate Jr CA, Du J, Schloesser RJ, McCammon J, Chen G et al. Biol Psychiatry 2008; 63: 349-352.
5. Machado-Vieira R, Salvadore G, Diazgranados N, Zarate Jr CA. Pharmacol Ther 2009; 123: 143-150.
6. De Sarno P, Bijur GN, Zmijewska AA, Li X, Jope RS. Neurobiol Aging 2006; 27: 413-422.
7. Li X, Jope RS. Neuropsychopharmacol 2010; 35: 2143-2154.
8. Jope RS, Johnson GV. Trends Biochem Sci 2004; 29: 95-102.
9. McManus EJ, Sakamoto K, Armit LJ, Ronaldson L, Shpiro N, Marquez R et al. EMBO J 2005; 24: 1571-1583.
10. Klein PS, Melton DA. Proc Natl Acad Sci USA 1996; 93: 8455-8459.